Sharekhan

Epigral Ltd

Fri 15/05/2026,15:52:24 | NSE : EPIGRAL

₹ 1216.40-32.10 (-2.57%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 1242.00

Previous Close

₹ 1248.50

Volume

23346

Mkt Cap ( Rs. Cr)

₹5247.71

High

₹ 1248.90

Low

₹ 1211.30

52 Week High

₹ 2114.00

52 Week Low

₹ 807.00

Book Value Per Share

₹ 496.10

Dividend Yield

0.40

Face Value

₹ 10.00

What’s Your Call?

Collective community sentiment on Epigral Ltd

Your Vote -

Buy

54.08%

Hold

41.84%

Sell

4.08%

54.08%

98 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

NaN%

Sell Order Quantity

NaN%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Epigral Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Epigral - Business Responsibility and Sustainability Reporting (BRSR)

    15 May 2026, 6:00PM BRSR of F.Y. 2025-26.
  • Epigral - Reg. 34 (1) Annual Report.

    15 May 2026, 5:58PM Annual Report of F.Y. 2025-26.
  • Epigral - Intimation Of 19Th AGM To Be Held On 08.06.2026.

    15 May 2026, 5:53PM Intimation of 19th AGM to be held on 08.06.2026.
  • Epigral has declared 50% Final dividend for the financial year March 2026

    15 May 2026, 12:41PM Epigral Ltd. on Monday, 04 May 2026, has announced Final dividend of 50 percent on Equity Share, to its shareholders holding shares on the register on
  • Epigral - Corporate Action-Board approves Dividend

    14 May 2026, 11:45AM Record Date for Dividend - 01.06.2026.
  • Epigral - Copy of Newspaper Publication

    14 May 2026, 11:40AM Epigral Limited has informed the Exchange about Copy of Newspaper Publication
  • Epigral - Record Date

    14 May 2026, 11:33AM Epigral Limited has informed the Exchange that Record date for the purpose of Dividend is 01-Jun-2026.
  • Epigral - Analysts/Institutional Investor Meet/Con. Call Updates

    12 May 2026, 11:15AM Epigral Limited has informed the Exchange about Schedule of meet
  • Epigral - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    12 May 2026, 11:17AM Intimation of One on One meeting on 15.05.2026.
  • Epigral - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    6 May 2026, 6:11PM Intimation of One-on-One Meeting through V.C. with Investor / Analyst on 8th May, 2026
  • Epigral - Analysts/Institutional Investor Meet/Con. Call Updates

    6 May 2026, 6:09PM Epigral Limited has informed the Exchange about Schedule of meet
  • Epigral - Analysts/Institutional Investor Meet/Con. Call Updates

    6 May 2026, 1:28PM Epigral Limited has informed the Exchange about Transcript
  • Epigral - Copy of Newspaper Publication

    5 May 2026, 2:37AM Epigral Limited has informed the Exchange about Copy of Newspaper Publication
  • Epigral - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    3 May 2026, 8:37PM Audio Recording of Conference Call discussing Q4 FY2026 Results held on Saturday, 2nd May, 2026 at 4.30 p.m.
  • Epigral - Analysts/Institutional Investor Meet/Con. Call Updates

    3 May 2026, 8:29PM Epigral Limited has informed the Exchange about Link of Recording
  • Epigral Q4 net profit down 5.41% at Rs 81.93 cr

    2 May 2026, 5:30PM The company reported standalone net profit of Rs 81.93 crore for the quarter ended March 31, 2026 as compared to Rs 86.62 crore in the same period las
  • Epigral - Dividend

    2 May 2026, 4:19PM Epigral Limited has informed the Exchange that Board of Directors at its meeting held on May 02, 2026, recommended Final Dividend of Rs. 5 per equity
  • Epigral - Corporate Action-Board approves Dividend

    2 May 2026, 4:15PM The Board of Directors recommended the Final Dividend of Rs.5.00 (50.00%) per Equity Share of face value of Rs.10 each for the F.Y. 2025-26.
  • Epigral - Press Release

    2 May 2026, 4:12PM Epigral Limited has informed the Exchange regarding a press release dated May 02, 2026, titled ""Press Release on Audited Financial Results Q4 & FY2
  • Epigral - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    2 May 2026, 4:10PM PRESS RELEASE - Q4 & FY2026.
  • Epigral - Investor Presentation

    2 May 2026, 4:08PM Epigral Limited has informed the Exchange about Investor Presentation
  • Epigral - Announcement under Regulation 30 (LODR)-Investor Presentation

    2 May 2026, 4:07PM Investor Presentation - Q4 & FY2026.
  • Epigral - FINANCIAL RESULTS 31.03.2026

    2 May 2026, 4:02PM APPROVAL OF AUDITED FINANCIAL RESULTS AS ON 31.03.2026.
  • Epigral - Board Meeting Outcome for Approved Audited Financial Results (Standalone & Consolidated) For The Fourth Quarter And

    2 May 2026, 3:57PM Approved Audited Financial Results (Standalone & Consolidated) for the Fourth Quarter and Year ended on 31st March, 2026 and Recommended Final dividen
  • Epigral - Outcome of Board Meeting

    2 May 2026, 3:52PM Epigral Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
  • Epigral - Analysts/Institutional Investor Meet/Con. Call Updates

    28 Apr 2026, 3:03PM The Company is having conference call to discuss the Q4FY26 results on Saturday, 2nd May, 2026 at 4.30 p.m. (IST)
  • Epigral - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    28 Apr 2026, 3:06PM The Company is having conference call to discuss the Q4FY26 results on Saturday, 2nd May, 2026 at 4.30 P.M. (IST)
  • Epigral - Board Meeting Intimation for Consideration & Approval Of Audited Financial Results For The Fourth Quarter And Year

    27 Apr 2026, 12:19PM Epigral Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/05/2026 ,inter alia, to consider and approve
  • Epigral has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2026

    20 Apr 2026, 4:30PM As of March 2026, 68.83% is owned by Indian Promoters and 31.17% by Public. <p align=justify> Top five Promoters holding highest number of shares of E
  • Epigral - Copy of Newspaper Publication

    19 Apr 2026, 9:57PM Epigral Limited has informed the Exchange about Copy of Newspaper Publication
  • Epigral - Shareholders meeting

    17 Apr 2026, 12:15PM Epigral Limited has informed the Exchange regarding Notice of Postal Ballot
  • Epigral - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

    17 Apr 2026, 12:13PM Postal Ballot notice for re-appointment of in the Non-Executive Directors for a 2nd term of five years.
  • Epigral - General Updates

    16 Apr 2026, 5:12PM Epigral Limited has informed the Exchange about Re-appointment of Non-Executive Independent Directors for Second Term.
  • Epigral - Re-Appointment Of Non-Executive Independent Directors For Second Term

    16 Apr 2026, 5:07PM Re-appointment of Non-Executive Independent Directors for Second Term.
  • Epigral - Analysts/Institutional Investor Meet/Con. Call Updates

    9 Apr 2026, 2:49PM Epigral Limited has informed the Exchange about Investors / Analysts meet scheduled on 13th April, 2026.
  • Epigral - Analysts/Institutional Investor Meet/Con. Call Updates

    9 Apr 2026, 2:45PM Epigral Limited has informed the Exchange about Investor / Analyst meet scheduled on 10th April, 2026.
  • Epigral - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    9 Apr 2026, 3:03PM Epigral Limited has informed the Exchange about Investors / Analysts meet scheduled on 13th April, 2026.
  • Epigral - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    9 Apr 2026, 2:55PM Epigral Limited has informed the Exchange about Investor / Analyst meet scheduled on 10th April, 2026.
  • Epigral - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    8 Apr 2026, 1:13PM Epigral Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
  • Epigral - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    8 Apr 2026, 1:25PM Epigral Limited submits Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 31.03.2026.
  • Epigral - Analysts/Institutional Investor Meet/Con. Call Updates

    7 Apr 2026, 3:16PM Epigral Limited has informed the Exchange about Schedule of meet
  • Epigral - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    7 Apr 2026, 3:13PM The Company is having a meeting with Locus Investment Group on 10.04.2026.
  • Epigral - Analysts/Institutional Investor Meet/Con. Call Updates

    4 Apr 2026, 12:01PM Epigral Limited has informed the Exchange about Schedule of meet
  • Epigral - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    4 Apr 2026, 11:57AM The Company is participating in Non-Deal Roadshow organized by Sunidhi Securities on 08.04.2026 at Mumbai.
  • Epigral - Trading Window

    27 Mar 2026, 4:48PM Epigral Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
  • Epigral - Analysts/Institutional Investor Meet/Con. Call Updates

    11 Mar 2026, 5:03PM Epigral Limited has informed the Exchange about One-on-One Meeting through V.C. with Investor / Analyst on 12th March, 2026.
  • Epigral - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    11 Mar 2026, 5:05PM Epigral Limited has informed the Exchange about One-on-One Meeting through V.C. with Investor / Analyst on 12th March, 2026.
  • Epigral - Analysts/Institutional Investor Meet/Con. Call Updates

    6 Mar 2026, 5:55PM Epigral Limited has informed the Exchange about One-on-One Meeting through V.C. with Investor / Analyst on 9th March, 2026
  • Epigral - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    6 Mar 2026, 5:57PM Epigral Limited has informed the Exchange about One-on-One Meeting through V.C. with Investor / Analyst on 9th March, 2026
  • Epigral - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    27 Feb 2026, 6:19PM Epigral Limited has informed that the Company is having One-on-One V.C. with Investor / Analyst on 2nd March, 2026.
  • Epigral - Analysts/Institutional Investor Meet/Con. Call Updates

    27 Feb 2026, 6:16PM Epigral Limited has informed that the Company is having One-on-One V.C. with Investor / Analyst on 2nd March, 2026.
  • Meghmani Finechem commissions captive PowerPlant of 36 MW at Dahej

    30 Sep 2022 , 10:50AM Meghmani Finechem commissions additional 1.06 lakh TPA capacity of caustic soda at Dahej
  • Meghmani Finechem commissions CPVC resin plant in Gujarat

    18 Jul 2022 , 12:12PM Meghmani Finechem commissions India’s largest Chlorinated Polyvinyl Chloride Resin (CPVC Resin) plant

Key fundamentals

Evaluate the intrinsic value of Epigral Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 2784.46 2488.11 2216.7777 1945.3109 1715.3315
Liabilities 2784.46 2488.11 2216.7777 1945.3109 1715.3315
Equity 43.14 43.14 41.5502 41.5502 41.5502
Gross Profit 567.07 710.72 481.2096 688.9974 509.4874
Net Profit 333.01 356.7 195.7877 353.3575 252.7868
Cash From Operating Activities 435.53 440.56 397.6901 626.1617 283.8167
NPM(%) 13.17 13.98 10.14 16.14 16.29
Revenue 2527.18 2550.13 1929.1916 2188.3997 1550.9414
Expenses 1960.11 1839.41 1447.982 1499.4023 1041.454
ROE(%) 15.55 16.66 9.14 16.51 11.81

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
01 Jun 2026 5 50 0.41 1328.7
20 Jun 2025 3.5 35 0.41 1779.6
07 Feb 2025 2.5 25 0.41 1788.2
02 Jul 2024 5 50 0.41 1398.9
20 Jun 2023 2.5 25 0.41 990.65
01 Feb 2023 2.5 25 0.41 1143.4

Peers

Other companies within the same industry or sector that are comparable to Epigral Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Nitta Gelatin India Ltd 1328.70 3.32 12.41 1108.75 1071.07 0.00
Sharda Cropchem Ltd 969.00 1.10 12.84 11017.73 754.66 1.55
Amines and Plasticizers Ltd 208.02 3.19 33.66 6719.04 372.61 0.24
Indogulf Cropsciences Ltd 61.55 -1.01 10.19 5957.87 49.78 0.00

Company Info

Our Company was incorporated as "Meghmani Finechem Limited" on September 11, 2007 under the Companies Act, 1956 in the state of Gujarat vide Certificate of Incorporation issued by the Registrar of Companies, Gujarat, Dadra and Nagar Haveli ("RoC"). Our Company obtained Certificate of Commencement of Business on September 17, 2007 issued by RoC.Key Events and Milestones:2007 -Received Certificate of Commencement of Business2008 -International Finance Corporation (World Bank) joined as a partner with 24.97% stake2010 -Started Operation from July 2009 as Greenfield Project of 1,19,000-FY 2010 TPA of Caustic Chlorine and Captive Power Plant of 40MW2015 -Expanded Caustic Chlorine to 1,67,000 TPA with 60MW Captive Power Plant2017 -Commissioned KOH Plant of 21,000 TPA and Convert all Membrane to FY 2017 ZERO Gap2018-Planned for New Caustic Expansion and Chlor-Alkali Derivatives (Chloromethane and Hydrogen Peroxide)-Achieved Turnover of USD 95 Million (? 609 Cr.)2019-Commissioned Chloromethane Plant2020-Commenced the Commercial Operations of Caustic Soda Lye Expansion of 140000 TPA with Captive Power Plant of 36 MW-Announcement for setting up new Epichlorohydrin Plant with 50,000 TPA capacity-Expanded Caustic Chlorine Capacity to 294,000TPA-Expanded capacity of Captive Power Plant to 96MW-Commissioned 60,000 TPA Hydrogen Peroxide Plant 2022 - The Company announced the successful commissioning of chlorinated polyvinyl chloride resin (CPVC resin) plant at Dahej in Gujarat. The newly-commissioned facility with a production capacity of 30,000 tonnes per annum (TPA) is the largest of its kind in India.  2023  -Company name has changed to Epigral Ltd. from Meghmani Finechem Ltd.. - 'Commissioning of Wind Solar Hybrid Power Plant'.  2024 -The Company Informed Commissioning of CPVC Compound Plant at its Dahej Facility at Gujarat.

Our Company was incorporated as "Meghmani Finechem Limited" on September 11, 2007 under the Companies Act, 1956 in the state of Gujarat vide Certificate of Incorporation issued by the Registrar of Companies, Gujarat, Dadra and Nagar Haveli ("RoC"). Our Company obtained Certificate of Commencement of Business on September 17, 2007 issued by RoC.Key Events and Milestones:2007 -Received Certificate of Commencement of Business2008 -International Finance Corporation (World Bank) joined as a partner with 24.97% stake2010 -Started Operation from July 2009 as Greenfield Project of 1,19,000-FY 2010 TPA of Caustic Chlorine and Captive Power Plant of 40MW2015 -Expanded Caustic Chlorine to 1,67,000 TPA with 60MW Captive Power Plant2017 -Commissioned KOH Plant of 21,000 TPA and Convert all Membrane to FY 2017 ZERO Gap2018-Planned for New Caustic Expansion and Chlor-Alkali Derivatives (Chloromethane and Hydrogen Peroxide)-Achieved Turnover of USD 95 Million (? 609 Cr.)2019-Commissioned Chloromethane Plant2020-Commenced the Commercial Operations of Caustic Soda Lye Expansion of 140000 TPA with Captive Power Plant of 36 MW-Announcement for setting up new Epichlorohydrin Plant with 50,000 TPA capacity-Expanded Caustic Chlorine Capacity to 294,000TPA-Expanded capacity of Captive Power Plant to 96MW-Commissioned 60,000 TPA Hydrogen Peroxide Plant 2022 - The Company announced the successful commissioning of chlorinated polyvinyl chloride resin (CPVC resin) plant at Dahej in Gujarat. The newly-commissioned facility with a production capacity of 30,000 tonnes per annum (TPA) is the largest of its kind in India.  2023  -Company name has changed to Epigral Ltd. from Meghmani Finechem Ltd.. - 'Commissioning of Wind Solar Hybrid Power Plant'.  2024 -The Company Informed Commissioning of CPVC Compound Plant at its Dahej Facility at Gujarat.

Read More

Parent Organisation

Epigral Ltd.

Founded

11/09/2007

Managing Director

Mr.Maulik Patel

NSE Symbol

EPIGRALEQ

FAQ

The current price of Epigral Ltd is ₹ 1216.40.

The 52-week high for Epigral Ltd is ₹ 1248.90 and the 52-week low is ₹ 1211.30.

The market capitalization of Epigral Ltd is currently ₹ 5247.71. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Epigral Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Epigral Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Epigral Ltd shares.

The CEO of Epigral Ltd is Mr.Maulik Patel, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT